Add BrightSurf on Google Email

Gene therapy gives mice broad protection to pandemic flu strains, including 1918 flu

Researchers develop a gene therapy that gives mice complete protection against lethal strains of H5N1 and H1N1 flu virus, including the infamous 1918 flu. The treatment involves expressing a broadly neutralizing antibody in nasal epithelial cells, providing substantial reductions in flu replication and virus load.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·DateMay 29, 2013

New tool better estimates pandemic threats

A new method better assesses pandemic risks by estimating transmissibility of emerging zoonotic viruses, such as the H3N2v-M virus, using routine surveillance data. This approach is simple and robust, but may not be suitable for non-subcritical outbreaks.

SourcePLOS·JournalPLOS Medicine·DateMar 5, 2013

Influenza study: Meet virus' new enemy

Scientists have discovered a new class of molecular compounds capable of killing the influenza virus. The compounds work by clogging up an enzyme that helps the virus spread, and are more effective because they are water-soluble. This breakthrough could buy scientists time to develop new vaccines for emerging strains of influenza.

SourceSimon Fraser University·JournalScience·DateFeb 21, 2013

NIH scientists reflect on gains in emerging infectious disease awareness, research and response

Over the past two decades, heightened awareness of emerging infectious diseases has improved diagnosis, treatment, and prevention through advances such as rapid genome sequencing. The complex interactions between microbes and human hosts are being better understood, leading to new insights into disease development and countermeasures.

Swine flu vaccination program a success in Scotland

A successful swine flu vaccination program in Scotland showed 77% protection against the H1N1 virus, while also reducing hospital admissions by 20% due to related disorders. The program's effectiveness was demonstrated through detailed data analysis, which took into account multiple conditions such as pneumonia and COPD.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 25, 2012

A SMART(er) way to track influenza

Brown University engineers create a biochip called SMART that can detect influenza by identifying specific RNA sequences and separating them from other biological debris. The device is small, low-cost, and fast, making it potentially useful in first-aid kits.

SourceBrown University·JournalJournal of Molecular Diagnostics·DateJun 11, 2012

Pandemic 2009 H1N1 vaccination produces antibodies against multiple flu strains

Researchers have made a significant discovery that the pandemic 2009 H1N1 vaccine can produce antibodies against not only the H1N1 virus but also other influenza virus strains including H5N1 and H3N2. This breakthrough brings the team closer to developing a pan-influenza vaccine that can reliably induce broadly cross-reactive antibodies.

SourceEmory Health Sciences·JournalProceedings of the National Academy of Sciences·DateMay 21, 2012

School closures slow spread of pH1N1

A McMaster University study finds that closing schools can significantly reduce the spread of pH1N1, with a 50% reduction in transmission observed. The research used high-quality data from Alberta to demonstrate the effectiveness of school closures as a control measure during pandemic outbreaks.

SourceMcMaster University·JournalAnnals of Internal Medicine·DateFeb 6, 2012

Mass gatherings offer unique opportunities to communicate public health messages about infectious disease threats and promote interventions to benefit global health

Mass gatherings provide a unique opportunity to promote vaccination and reduce the spread of infectious diseases, as seen in outbreaks at World Youth Day and music festivals. Coordinated risk assessment and management are key to preventing disease transmission during and after events.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJan 15, 2012

The H1N1 flu vaccine protects both pregnant women and newly-borns

A study of 107 pregnant women found that the H1N1 flu vaccine boosted their immune system and protected their newborns via transplacental transfer of antibodies. The results show that the influenza vaccine is safe during pregnancy and recommended for pregnant women to protect themselves and their babies.

Annals of Internal Medicine tip sheet for Dec. 6, 2011

Recent studies have shed light on the rising trend of total knee replacements, with researchers finding that increasing knee pain may be a contributing factor. Additionally, a single dose of influenza vaccine administered during pregnancy has been shown to protect both mothers and their newborns from swine flu. Meanwhile, a review of s...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateDec 5, 2011

New hi-tech survey accelerates collection of vaccination data

Researchers used new technologies to collect near-real-time data on vaccination side effects in Scotland, revealing no significant safety issues with the 2009-10 swine flu vaccine. The study adds to evidence supporting the safety of vaccination campaigns and could inform future studies using web-based technology.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateNov 15, 2011

Global flu watch: Report of rare flu coinfection in Southeast Asia hot spot

Researchers have confirmed a rare incidence of individuals becoming infected with both seasonal and pandemic strains of the flu at the same time. Experts say this highlights the ongoing risk of distinct flu viruses combining in human hosts, particularly in Southeast Asia where avian influenza and pandemic H1N1 are prevalent.

SourceBurness·JournalAmerican Journal of Tropical Medicine and Hygiene·DateNov 2, 2011

News tips from the journal mBio

Antibodies have been found to trick certain bacteria into killing each other, providing a new mechanism for bacterial clearance. Additionally, researchers suggest that humoral immunity may play a role in eliminating old seasonal influenza virus strains by inducing an anti-stalk antibody response.

Stem cells repair lung damage after flu infection

Researchers have identified adult stem cells that can regenerate lung tissue, providing hope for new treatments of acute and chronic airway diseases. The findings suggest that the lungs have a remarkable ability to regenerate after infection, with stem cells proliferating rapidly and assembling into alveolar-like structures.

SourceCell Press·JournalCell·DateOct 27, 2011

Twitter data used to track vaccination rates and attitudes

A Penn State University study analyzed tweets about the H1N1 vaccine to track vaccination rates and attitudes. The research found patterns that correlate vaccination rates with geographic location and sentiment trends over time. This analysis could be used strategically to develop targeted public health initiatives.

SourcePenn State·JournalPLOS Computational Biology·DateOct 13, 2011

Could the Spanish flu devastate us again?

Researchers at Tel Aviv University have developed a unique computational method to analyze the H1N1 virus, identifying key mutation strategies that led to the 2009 pandemic. This method reveals crucial differences between the pandemic strain and common seasonal H1N1 strains, shedding light on potential vaccine development.

SourceAmerican Friends of Tel Aviv University·JournalProceedings of the National Academy of Sciences·DateAug 15, 2011